false 0001540013 00-0000000 0001540013 2026-03-13 2026-03-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 March 13, 2026 Date of Report (Date of earliest event reported) Quipt
Home Medical Corp. (Exact name of registrant as specified in its
charter) British
Columbia, Canada (State or other jurisdiction of incorporation) 001-40413 N/A (Commission
    File Number) (IRS
                                         Employer Identification No.) 1019
    Town Drive Wilder , Kentucky ​ 41076 (Address
    of principal executive offices) ​ (Zip
    Code) ( 859 ) 878-2220 (Registrant’s telephone
number, including area code) Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title
    of each class Trading
    Symbol(s) Name
    of each exchange on which registered Common
    Shares, without Par Value ​ QIPT ​ The Nasdaq Capital
    Market Toronto Stock Exchange Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth
company x If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ INTRODUCTORY NOTE On March 16, 2026 (the “Closing
Date”), Quipt Home Medical Corp., a corporation existing under the laws of British Columbia (“Quipt”), announced the
closing of its previously announced transaction with 1567208 B.C. Ltd., a company incorporated under the laws of British Columbia (the
“Purchaser”), and REM Aggregator, LLC, a Delaware limited liability company (“Parent”), pursuant to the previously
announced arrangement agreement dated December 14, 2025 (the “Arrangement Agreement”), by and among Quipt, the Purchaser and
Parent. Pursuant to the terms of the Arrangement Agreement, among other things, the Purchaser acquired all of the issued and outstanding
common shares (collectively, the “Shares”) of Quipt on the Closing Date for US$3.65 per Share in cash (the “Consideration”),
by way of a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”). Item 1.01 The information set forth in the Introductory
Note of this Current Report on Form 8-K is incorporated by reference into this Item 1.01. Parent obtained incremental debt financing for
the purpose of facilitating the transactions contemplated by the Arrangement Agreement. On March 13, 2026, Parent entered into an amendment
to that certain amended and restated credit and guaranty agreement, initially dated as of September 16, 2022 (as amended, restated, increased,
extended, supplemented or otherwise modified from time to time, by and among, Parent, REM Borrower, LLC, a Delaware limited liability
company, as the borrower, and Quipt, as a guarantor, and the other persons party thereto from time to time as loan parties, the lenders
party thereto from time to time and First-Citizens Bank & Trust Company, as administrative agent, which provides for incremental revolving
loan capacity. Item 2.01. Completion of Acquisition or Disposition
of Assets. In connection with the Arrangement,
at 12:01 a.m. (Vancouver Time) (the “Effective Time”) on the Closing Date, Purchaser acquired all of the issued and outstanding
Shares of Quipt and Quipt became a wholly owned indirect subsidiary of Parent. At the Effective Time, (i)
each Share outstanding immediately prior to the Effective Time, other than Shares held by a dissenting holder of Shares who has validly
exercised such holder’s dissent rights, was deemed to be assigned and transferred by the holder thereof to the Purchaser in exchange
for the Consideration for each Share held; (ii) each option to purchase Shares (an “Option”) outstanding immediately prior
to the Effective Time, whether vested or unvested, was deemed to be unconditionally vested and exercisable and such Options were deemed
to be surrendered and transferred to Quipt in exchange for a cash payment by or on behalf of Quipt in respect of each Share subject to
each Option equal to the amount (if any) by which the Consideration exceeded the exercise price of such Option, subject to applicable
tax withholdings, and such Option was cancelled immediately after its transfer; and (iii) each restricted share unit (an “RSU”)
outstanding immediately prior to the Effective Time, whether vested or unvested, was deemed to be transferred to Quipt in exchange for
the Consideration for such RSU, subject to applicable tax withholdings, and such RSU was cancelled immediately after its transfer. The
aggregate consideration payable by the Purchaser to acquire the Shares, Options and RSUs outstanding immediately prior to the Effective
Time is approximately $173 million. The
foregoing description of the Arrangement Agreement and the Arrangement does not purport to be complete and is subject to, and qualified
in its entirety by, the full text of the Arrangement Agreement, a copy of which is attached as Exhibit 2.1 to Quipt’s Current Report
on Form 8-K filed with the U.S. Securities and Exchange Commission on December 15, 2025, the terms of which are incorporated herein by
reference. The information contained in the Introductory Note and Items 3.01, 3.03, 5.01, 5.02 and 8.01
of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. Item 3.01. Notice of Delisting or Failure to
Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Quipt notified the Nasdaq
Stock Market (“NASDAQ”) that, as of the Effective Time, each Share issued and outstanding immediately prior to such time was
acquired by the Purchaser. On the Closing Date, in connection with the completion of the Arrangement, Quipt requested NASDAQ to promptly
file with the SEC a Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), on Form 25 to delist the Shares from the NASDAQ and deregister the Shares under Section 12(b)
of the Exchange Act. Upon effectiveness of such Form 25, Quipt intends to file with the SEC a Certification and Notice of Termination
on Form 15 to terminate the registration of the Company’s Shares under Section 12(g) the Exchange Act and request that Quipt’s
reporting obligations under Sections 13 and 15(d) of the Exchange Act be suspended. On the Closing Date, Quipt
also notified the Toronto Stock Exchange (“TSX”) that the Arrangement had been completed. The Shares are expected to be delisted
from the TSX on or about March 17, 2026. Quipt intends to promptly apply to cease to be a reporting issuer in each province and territory
of Canada. Trading of the Shares on the
NASDAQ was halted prior to the opening of trading on the Closing Date. The Shares will cease trading on the TSX at the close of business
on March 17, 2026. The information set forth
in the Introductory Note and Items 2.01 and 3.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. Item 3.03. Material Modification to Rights
of Security Holders. On March 16, 2026, in connection
with the completion of the Arrangement, each Share that was issued and outstanding immediately prior to the Effective Time was converted
into the right to receive the Consideration at the Effective Time. The information contained
in the Introductory Note and Items 2.01, 3.01 and 5.01 of this Current Report on Form 8-K is incorporated by reference into this Item
3.03. Item 5.01. Changes in Control of Registrant. In connection with the Arrangement,
a change of control of Quipt occurred and Quipt became a wholly owned indirect subsidiary of Parent. The information contained
in the Introductory Note and Items 2.01, 3.01, 3.03 and 5.02 of this Current Report on Form 8-K is incorporated by reference into this
Item 5.01. Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. In connection with the completion
of the Arrangement and in accordance with the Arrangement Agreement, effective as of the Effective Time, Mark Greenberg, Kevin Carter,
and Brian Wessel resigned from Quipt’s board of directors (the “Board”) and any committees thereof, and the following
persons were appointed to the Board: Stephen Griggs; Michael Niegsch; and Johnny Wilhelm. Gregory Crawford, Quipt’s Chief Executive
Officer and a member of the Board prior to completion of the Arrangement, remains on the Board. Additionally, in accordance with the Arrangement
Agreement and effective as of the Effective Time, Hardik Mehta (Chief Financial Officer and Principal Financial Officer) and Thomas Roehrig
(Chief Accounting Officer and Principal Accounting Officer) resigned as officers of Quipt. Following the Effective Time, each of Hardik
Mehta and Thomas Roehrig were reappointed as Quipt’s Chief Financial Officer and Chief Accounting Officer, respectively, and Stephen
Griggs was appointed as Executive Chairman of Quipt. Gregory Crawford will continue to serve as Quipt’s Chief Executive Officer. The information set forth
in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02. Item 8.01. Other Events. Incorporated by reference
is Exhibit 99.1 attached hereto, a press release issued by Quipt on March 16, 2026 announcing the completion of the Arrangement. Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit Number Description 2.1 † Arrangement Agreement, dated as of December 14, 2025, between Quipt Home Medical Corp., a British Columbia corporation, 1567208 B.C. LTD, a company existing under the laws of British Columbia and REM Aggregator, LLC, a Delaware company (incorporated by reference to Exhibit 2.1 to Quipt’s Current Report on Form 8-K filed on December 15, 2025) 99.1 Press release issued by Quipt Home Medical Corp. on March 16, 2026 104 Cover Page Interactive Data File (formatted as Inline XBRL and embedded
    within the Inline XBRL document) † Certain of the exhibits and schedules to this exhibit have
    been omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of all omitted exhibits
    and schedules to the SEC upon its request. SIGNATURES Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Quipt Home Medical Corp. Date: March 16, 2026 By: /s/ Hardik Mehta Hardik Mehta Chief Financial Officer

Quipt Home Medical Corp. was successfully acquired by 1567208 B.C. Ltd. for US$3.65 per share in cash on March 16, 2026, marking a complete change in ownership and strategic direction for the home healthcare company.

On March 16, 2026, Quipt Home Medical Corp. announced the closing of its acquisition transaction with 1567208 B.C. Ltd. and REM Aggregator, LLC. Under the terms of the arrangement agreement dated December 14, 2025, the Purchaser acquired all issued and outstanding common shares of Quipt for US$3.65 per Share. This transaction involved a plan of arrangement under the Business Corporations Act of British Columbia. The key impact of this acquisition is the shift in ownership and strategic direction for Quipt, aiming to enhance its operational capacity and market reach.

Real-time funding, M&A, exec moves & hiring — the signals that move deals

Quipt Home Medical Corp.

AI Executive Summary

Key Takeaways

Raw Filing Content

Filing Overview

What This Means